Informed consent for prostate-specific antigen testing

Urology

Volumn 61, Issue 1, 2003, Pages 5-6

  Gann, Peter H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER RISK; CANCER SCREENING; DECISION MAKING; DISEASE SEVERITY; EDITORIAL; HEALTH CARE; HEART AUSCULTATION; HEART DISEASE; HUMAN; INFORMED CONSENT; MALE; MEDICAL INFORMATION; PATIENT INFORMATION; PERCEPTION; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RISK FACTOR; SCREENING TEST; SURGICAL TECHNIQUE;

HEALTH CARE AND PUBLIC HEALTH; PROFESSIONAL PATIENT RELATIONSHIP;

HUMANS; INFORMED CONSENT; MALE; MALPRACTICE; MASS SCREENING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 0037256672     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02157-X     Document Type: Editorial

References (4)

1. Etzioni R., Penson D.F., Legler J.M., et al. Over diagnosis due to prostate-specific antigen screening lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 94:2002;981-990.
2. Christiansen C.L., Wang F., Barton M.B., et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst. 92:2000;1657-1666.
3. Smith D.S., Catalona W.J., Herschman J.D. Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA. 276:1996;1309-1315.
4. Etzioni R, Legler JM, Feuer EJ, et al: Cancer surveillance series: interpreting trends in prostate cancer - part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 91: 1033-1039, 1999.